|Articles|August 1, 2002
SNB, tumor thickness keys to recurrence prediction
London - While sentinel node biopsy (SNB) is an accurate staging procedure to use when making the decision on adjuvant treatment in all patients with tumors more than 1mm thick, SNB is not the only parameter to be considered.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Transformative Advances This Year and Beyond
2
FDA Proposes Expansion of US Sunscreen Ingredient Standards with Bemotrizinol
3
Phase 3b Study Confirms Ligelizumab’s Consistent CSU Control
4
"PDE4 Inhibitor-Responsive Dermatoses": A Modern Framework for Managing Inflammatory Skin Conditions
5














